NEUWAY Pharma
Bonn, Nordrhein-Westfalen, Germany
About NEUWAY Pharma
NEUWAY Pharma is committed to bringing transformative neuropharmaceuticals across the blood-brain barrier through its EnPC®, the drug delivery technology based on a natural derived protein capsule. In addition to advancing its proprietary pipeline, the company aims to be a partner of choice in particular for antibody and mRNA drug developers stymied by the hurdles of delivering these and other drug modalities into the brain and CNS tissue. Operating as a drug developer and a delivery expert, NEUWAY will demonstrate the value of its technology through its internal orphan neurological disease pipeline and partnered programs.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $7.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2015)
- Website: neuway-pharma.com
- Phone: 49 228 522 798 0
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/neuway-pharma-2543731 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.